Publications by authors named "Colin Graydon"

Claim this Profile
C
Comparative analysis of LAG3 antibodies shows differential binding patterns by flow cytometry.
Colin G Graydon, Allison Balasko, Monika Kowatsch, Keith R Fowke

J Immunol Methods· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function.
Allison L Balasko, Monika M Kowatsch, Colin Graydon, Julie Lajoie, Keith R Fowke

Sci Rep· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel in vitro invariant natural killer T cell functional assays.
Allison Balasko, Colin Graydon, Keith R Fowke

J Immunol Methods· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LAG3's Enigmatic Mechanism of Action.
Colin G Graydon, Shifa Mohideen, Keith R Fowke

Front Immunol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies to Increase Productivity, Improve Performance, and Decrease Stress Levels in Surgical Training: Perspectives From the Younger Generation.
Richard Wagner, Colin Graydon, Oliver Johannes Deffaa

Ann Surg· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roles, function and relevance of LAG3 in HIV infection.
Colin G Graydon, Allison L Balasko, Keith R Fowke

PLoS Pathog· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of MicroRNA-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension.
François Potus, Grégoire Ruffenach, Abdellaziz Dahou, Christophe Thebault, Sandra Breuils-Bonnet, Colin Graydon

Circulation· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miRNAs in PAH: biomarker, therapeutic target or both?
Jolyane Meloche, Aude Pflieger, Mylène Vaillancourt, Colin Graydon, Steeve Provencher

Drug Discov Today· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension.
François Potus, Simon Malenfant, Colin Graydon, Vincent Mainguy, Ève Tremblay

Am J Respir Crit Care Med· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular remodeling process in pulmonary arterial hypertension, with focus on miR-204 and miR-126 (2013 Grover Conference series).
François Potus, Colin Graydon, Steeve Provencher, Sébastien Bonnet

Pulm Circ· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role for DNA damage signaling in pulmonary arterial hypertension.
Jolyane Meloche, Aude Pflieger, Mylène Vaillancourt, Roxane Paulin, François Potus, Colin Graydon

Circulation· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granzyme B deficiency exacerbates lung inflammation in mice after acute lung injury.
Jeremy A Hirota, Paul R Hiebert, Matt Gold, Dan Wu, Colin Graydon

Am J Respir Cell Mol Biol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis